Gretchen Simmons: Anyone Can Have a Blood Clot – No One Knows This Better Than Carol West
Gretchen Simmons, Associate Director for Communications at the Centers for Disease Control and Prevention (CDC), reposted from Thomas Reiser on LinkedIn:
”Anyone can have a blood clot.
No one knows this better than Carol West who fell on a rainy day and shattered her kneecap.
Listen to this episode of the Pulse Podcast to hear how her accident led to her developing blood clots in both legs which broke apart and moved to her lungs.
Then check out the resources here to learn the signs and symptoms of a blood clot and to learn more about the factors that put you at risk for dangerous blood clots including the ones Carol describes such as injury to a vein, surgery/hospitalization, and immobility.”
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
”Listen to the new episode of the International Society on Thrombosis and Haemostasis (ISTH) Pulse Podcast feat.
World Thrombosis Day Patient Ambassador Carol West who highlights the vital role patients play in raising awareness, driving research and inspiring change.
In her interview with host Geoffrey Barnes.”
Listen to the podcast here.
Stay tuned with Hemostasis Today.
-
Oct 9, 2025, 06:44Gretchen Simmons: Anyone Can Have a Blood Clot - No One Knows This Better Than Carol West
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 9, 2025, 07:14Ami Bhatt: The link Between Inflammation and Atherosclerotic Cardiovascular Disease Is No Longer Theoretical
-
Oct 9, 2025, 06:59Courtney Lawrence: It's Critical That as Blood Donor Eligibility Criteria Evolves
-
Oct 9, 2025, 06:55All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
-
Oct 9, 2025, 06:52Cihan Ay and Colleagues on Large Language Models VS Thrombosis Experts
-
Oct 9, 2025, 06:48A Neopoterian Theory of Global Bioethics from Henri-Corto Stoeklé and Christian Hervé
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 9, 2025, 07:15Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
-
Oct 9, 2025, 07:07Rahaf Ajaj: It’s About How Deeply Your Idea Can Reshape The World
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors